Coming together to combat COVID-19

SGI-DNA is empowering researchers with the tools and resources they need to develop vaccines, therapeutics, and diagnostics for the SARS-CoV-2 virus

The spread of COVID-19

How SARS-CoV-2 has mutated

SGI-DNA is here to address the shortage with the BioXp™ system, a DNA printer that can produce the parts for the entire ~30kb genome of SARS-CoV-2 (the causal agent of COVID-19) in a single overnight run, supporting development of diagnostics, therapeutics and vaccines.  Read the app note

SARS-CoV-2 Tools and Resources

BioXp reagents

Out team of synthetic biologists can help you design your gene constructs, whether you want to build a spike protein or a complete genome

Synthetic DNA services

You design it, no matter how simple or complex, and we build it at our facility and ship it to you with the industry's leading turn-around time 

Strategic collaborations

We are actively partnering where our synthetic DNA expertise will advance the development of vaccines, therapeutics, or diagnostics

Defeat COVID-19 and whatever might come next 

Are you working hard in this fight? We’re in your corner.

$50,000 co-funding

SGI-DNA is donating $50,000 towards the purchase of a BioXp™ system for front-line researchers conducting research and development on SARS-CoV-2.

More info

Coronavirus app note

Learn how you can use the BioXp™ system to create custom DNA in the fight against the coronavirus.

Download app note

Interested in collaborating or want more info?

How the BioXp™ system works

Order DNA

Login to the BioXp™ ordering portal and submit your DNA sequences

Receive cartridges

Cartridges containing the pieces of your desired gene(s) arrive in 3 to 5 days

Run the BioXp™ system

Load the cartridges and walk away — your finished product can be ready in as little as 3 hours

Sources:

1. Genomic epidemiology of novel coronavirus imagery courtesy of https://nextstrain.org/ncov

2. New York Times quote coutesty of Thomas, K (2020, March 12), As Coronavirus Testing Increases, Some Labs Fear a Shortage of Other Supplies, The New York Times, https://www.nytimes.com/